Users online: 2136    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2016, Volume : 9, Issue : 9
First page : ( 1519) Last page : ( 1523)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2016.00297.3

Pathogenesis and Novel Drug for Treatment of Asthma-A Review

Dave Pavithra H.1,*, Dr. Preetha2

11BDS, Saveetha Dental College and Hospitals, No 162, PH Road, Chennai-600077

2Lecturer, Department of Physiology, Saveetha Dental College and Hospitals, Chennai-600077

*Corresponding Author E-mail: pavithrahdave@yahoo.com

Online published on 12 January, 2017.


Asthma prevails and affects almost 20 million people in the United States and more than 300 million people worldwide. Asthma is a heterogeneous group of conditions. Obstructive airway illnesses are manifested with chronic inflammation affecting the whole respiratory tract. Obstruction and hindrance is usually intermittent and reversible in asthma, emotional stress can either precipitate or provoke both acute and chronic asthma. New drugs are needed because those that are currently available cannot control symptoms and hinder in the patients and can cause adverse reactions. The development of small molecule therapeutics and biologic agents may improve asthma care in the future. Effective treatment of severe asthma is a major unmet need because patients’ symptoms are not controlled on treatment with inhaled therapy. This review discusses the recent advances and the evidence for current available strategies targeting the pathogenesis and drugs for this time critical emergency.



Corticosteroids, pathology, asthma, drugs.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
596,263,479 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.